Harnessing microbial iron chelators to develop innovative therapeutic agents.

Area of Science:

• Microbiology
• Medicinal Chemistry
• Drug Discovery

Background:

• Multidrug-resistant Gram-negative bacteria pose a critical threat due to the ongoing antibiotic crisis.
• Bacterial evolution necessitates the urgent discovery of novel antimicrobial agents.
• Microbial iron acquisition pathways, particularly siderophores, present a promising avenue for developing advanced antimicrobial strategies.

Purpose of the Study:

• To review the evolutionary trajectory of siderophores from ancient forms to modern iron chelating agents.
• To provide a forward-looking perspective on siderophore research for therapeutic applications.
• To stimulate innovation in the design of novel antimicrobial and iron-chelating compounds.

Main Methods:

• Review of existing literature on siderophore evolution and applications.
• Analysis of the mechanism of action of siderophore-mimicking antibiotics.
• Evaluation of recent advancements in iron chelating compound development.

Main Results:

• Siderophore-mimicking antibiotics demonstrate high efficacy and selectivity against Gram-negative pathogens, including multidrug-resistant strains.
• Cefiderocol, a novel siderophore antibiotic, effectively treats multidrug-resistant Gram-negative infections via a "Trojan horse" mechanism.
• New iron chelating compounds show promise for treating iron overload and cancer, despite clinical application challenges.

Conclusions:

• Siderophore-based approaches offer a powerful strategy for combating antibiotic resistance and treating iron-related diseases.
• The structural diversity of siderophores provides a rich scaffold for designing innovative therapeutic agents.
• Continued research into siderophores is crucial for addressing unmet medical needs in infectious diseases, cancer, and iron overload conditions.